You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DEPO-ESTRADIOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Depo-estradiol patents expire, and what generic alternatives are available?

Depo-estradiol is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in DEPO-ESTRADIOL is estradiol cypionate. There are seventy-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estradiol cypionate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DEPO-ESTRADIOL?
  • What are the global sales for DEPO-ESTRADIOL?
  • What is Average Wholesale Price for DEPO-ESTRADIOL?
Drug patent expirations by year for DEPO-ESTRADIOL
Drug Prices for DEPO-ESTRADIOL

See drug prices for DEPO-ESTRADIOL

Recent Clinical Trials for DEPO-ESTRADIOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Anna Stanhewicz, PhDEarly Phase 1
McGill University Health Centre/Research Institute of the McGill University Health CentrePhase 4
Alexion Pharmaceuticals, Inc.Phase 1

See all DEPO-ESTRADIOL clinical trials

Pharmacology for DEPO-ESTRADIOL
Drug ClassEstrogen
Mechanism of ActionEstrogen Receptor Agonists

US Patents and Regulatory Information for DEPO-ESTRADIOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer DEPO-ESTRADIOL estradiol cypionate INJECTABLE;INJECTION 085470-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer DEPO-ESTRADIOL estradiol cypionate INJECTABLE;INJECTION 085470-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer DEPO-ESTRADIOL estradiol cypionate INJECTABLE;INJECTION 085470-003 Approved Prior to Jan 1, 1982 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.